Video

Dr. Gomella on Jefferson's Multidisciplinary Cancer Center

Author(s):

Leonard G. Gomella, MD

Leonard G. Gomella, MD from Jefferson Kimmel Cancer Center elaborates on the Multidisciplinary Cancer Center

Related Videos
Hope S. Rugo, MD
Amrita Krishnan, MD, executive medical director, Hematology, director, Judy and Bernard Briskin Multiple Myeloma Center, professor, Department of Hematology & Hematopoietic Cell Transplantation, City of Hope
Idoroenyi Amanam, MD
Francisco Hernandez-Ilizaliturri, MD, professor, oncology, Department of Medicine—Lymphoma; director, Lymphoma Research, head, Lymphoma Translational Research Lab; associate professor, Department of Immunology, Roswell Park Comprehensive Cancer Center; clinical professor, Department of Medicine, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo
Srikala Sridhar, MD, MSc, FRCPC
Andrea Wolf, MD, MPH
Suzanne Lentzsch, MD, PhD
Domenica Lorusso, MD, PhD
Martin H. Voss, MD
Jacob Sands, MD
Related Content
Sunvozertinib in EGFR exon 20–positive NSCLC Sunvozertinib in EGFR exon 20–positive NSCLC | Image Credit: © blueringmedia - stock.adobe.com
October 11th 2024

NMPA Grants Marketing Approval to NGS-Based Companion Diagnostic for Sunvozertinib in EGFR Exon 20+ NSCLC

Neeraj Agarwal, MD
July 17th 2023

FDA Approval Insights: Talazoparib Plus Enzalutamide in HRR Gene–Mutated mCRPC

Neal Shore, MD, FACS, steering committee chair, medical director, Carolina Urologic Research Center
October 9th 2024

Apalutamide Demonstrates Real-World OS Benefit vs Enzalutamide in mCSPC

Andrew J. Armstrong, MD, MSc
June 15th 2023

FDA Approval Insights: Olaparib Plus Abiraterone in BRCA-Mutated mCRPC

Neeraj Agarwal, MD, FASCO
October 8th 2024

PARP1-Selective Inhibitors Generate Excitement in Solid Tumors

Kevin Richardson, chief executive officer, Telix Precision Medicine
October 7th 2024

Health Canada Expands Indication for Illuccix Diagnostic Kit for PSMA-Targeted Radioligand Therapy in mCRPC